A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia

Trial Profile

A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs CSTC 1 (Primary)
  • Indications Alzheimer's disease; Vascular dementia
  • Focus Therapeutic Use
  • Sponsors Charsire Biotechnology Corporation
  • Most Recent Events

    • 26 Jul 2017 Last checked against ClinicalTrials.gov record.
    • 18 Jul 2017 Planned initiation date changed from 1 Mar 2017 to 1 Dec 2017.
    • 17 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top